Literature DB >> 33860514

Anticoagulation in Critically Ill Adults during Extracorporeal Circulation.

Nina Buchtele1, Thomas Staudinger1, Anne-Kristin Schäfer2, Magdalena Sophie Bögl3, Christian Schoergenhofer4, Michael Schwameis3.   

Abstract

Extracorporeal circuits including renal replacement therapy, extracorporeal membrane oxygenation, and ventricular assist devices are increasingly used in critically ill patients. The need for anticoagulation to provide circuit patency and avoid thrombosis remains a challenging task for treating physicians. In the presence of overall low scientific evidence concerning the optimal anticoagulants, monitoring tests, and therapeutic target ranges, recommendations are largely expert opinions and most centers use individual "in-house" anticoagulation protocols. This review gives a practical view on current concepts of anticoagulation strategies in patients with extracorporeal assist devices. Thieme. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33860514     DOI: 10.1055/a-1389-8216

Source DB:  PubMed          Journal:  Hamostaseologie        ISSN: 0720-9355            Impact factor:   1.778


  2 in total

1.  The role of nafamostat mesilate as a regional anticoagulant during extracorporeal membrane oxygenation.

Authors:  Jae Ha Lee; Jin Han Park; Ji Hoon Jang; Se Hun Kim; Sung Yong Hong; Woon Heo; Dong-Hwan Lee; Hye Sook Choi; Ki Hoon Kim; Hang-Jea Jang
Journal:  Acute Crit Care       Date:  2022-04-20

2.  Subcutaneous Enoxaparin for Systemic Anticoagulation of COVID-19 Patients During Extracorporeal Life Support.

Authors:  Marion Wiegele; Daniel Laxar; Eva Schaden; Andreas Baierl; Mathias Maleczek; Paul Knöbl; Martina Hermann; Alexander Hermann; Christian Zauner; Johannes Gratz
Journal:  Front Med (Lausanne)       Date:  2022-07-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.